Funder: National Institutes of Health

Due Dates: June 25, 2025 | October 25, 2025 | February 25, 2026 | June 25, 2026 | October 25, 2026 | February 25, 2027 | June 25, 2027 | October 25, 2027 (Letters of Intent due 30 days prior to each deadline)

Funding Amounts: Up to $225,000/year; $450,000 direct costs over 3 years (no pilot trial) or $600,000 direct costs over 3 years (with pilot/feasibility trial); max project period: 3 years.

Summary: Supports planning activities and preparatory studies to address information gaps and improve the design and feasibility of future cancer prevention and control clinical trials.

Key Information: Updated March 2025: Carefully review the full NOFO for recent changes; preliminary efficacy/effectiveness data for the future intervention is required at application.